Vikas Gupta MD, PhD

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 10

Article

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

by Ruben A. Mesa; Jason Gotlib; Vikas Gupta; John V. Catalano; Michael W. Deininger; Alan L. Shields; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Thomas Hare; Susan Erickson-Viitanen; William Sun; Victor Sandor; Richard S. Levy; Hagop M. Kantarjian; Srdan Verstovsek

2013

Article

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael Deininger; Carole Miller; Richard T. Silver; Moshe Talpaz; Elliott F Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013

Article

B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency

by Vikas Gupta; Michelle L. Hermiston; Gail Cassafer; David I. Daikh; Arthur Weiss

2008

Article

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

by Benjamin G. Barwick; Paola Neri; Nizar J. Bahlis; Ajay Nooka; Madhav Dhodapkar; David L. Jaye; Craig Hofmeister; Jonathan Kaufman; Vikas Gupta; Daniel Auclair; Jonathan J. Keats; Sagar Lonial; Paula Vertino; Lawrence Boise

2019

Article

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael W. N. Deininger; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth O. Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013

Article

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

by Ruben A. Mesa; Jean-Jacques Kiladjian; Srdan Verstovsek; Haifa Kathrin Al-Ali; Jason Gotlib; Heinz Gisslinger; Richard Levy; Andres Siulnik; Vikas Gupta; Mahmudul Khan; John F. DiPersio; Mari McQuitty; John V. Catalano; Deborah S. Hunter; Laurent Knoops; Michael Deininger; Francisco Cervantes; Carole Miller; Alessandro M. Vannucchi; Richard T. Silver; Tiziano Barbui; Moshe Talpaz; Giovanni Barosi; Elliot F. Mendeson; Elliott Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; ROnald Paquette; Azra Raza; William Sun; Victor Sandor; Hagop M. Kantarjian; Claire Harrison

2014

Article

Cytogenetic Risk Determines Outcomes After Allogeneic Transplantation in Older Patients With Acute Myeloid Leukemia in Their Second Complete Remission: A Center for International Blood and Marrow Transplant Research Cohort Analysis

by Fotios V. Michelis; Vikas Gupta; Mei-Jie Zhang; Hai-Lin Wang; Mahmoud Aljurf; Ulrike Bacher; Amer Beitinjaneh; Yi-Bin Chen; Zachariah DeFilipp; Robert Peter Gale; Partow Kebriaei; Mohamed Kharfan-Dabaja; Hillard M. Lazarus; Taiga Nishihori; Richard F. Olsson; Betul Oran; Armin Rashidi; David A. Rizzieri; Martin S. Tallman; Marcos de Lima; H Jean Khoury; Brenda M. Sandmaier; Daniel Weisdorf; Wael Saber

2017